The role and mechanism of glutamic NMDA receptor in the mechanical hyperalgesia in diabetic rats

References

• Chatterjee S , Khunti K , Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239–2251.10.1016/S0140-6736(17)30058-2
   PubMed Web of Science ®Google Scholar
• Chan JC , Zhang Y , Ning G . Diabetes in China: a societal solution for a personal challenge. Lancet Diabetes Endocrinol. 2014;2:969–979.10.1016/S2213-8587(14)70144-5
   PubMed Web of Science ®Google Scholar
• Gao F , Zheng ZM . Animal models of diabetic neuropathic pain. Exp Clin Endocrinol Diabetes. 2014;122:100–106.
   PubMed Web of Science ®Google Scholar
• Obrosova IG . Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics. 2009;6:638–647.10.1016/j.nurt.2009.07.004
   PubMed Web of Science ®Google Scholar
• Pop-Busui R , Boulton AJ , Feldman EL , et al . Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136–154.10.2337/dc16-2042
   PubMed Web of Science ®Google Scholar
• Shi J , Jiang K , Li Z . Involvement of spinal glutamate transporter-1 in the development of mechanical allodynia and hyperalgesia associated with type 2 diabetes. J Pain Res. 2016;9:1121–1129.10.2147/JPR
   PubMed Web of Science ®Google Scholar
• Griggs RB , Donahue RR , Adkins BG , et al . Pioglitazone inhibits the development of hyperalgesia and sensitization of spinal nociresponsive neurons in type 2 diabetes. J Pain. 2016;17:359–373.10.1016/j.jpain.2015.11.006
   PubMed Web of Science ®Google Scholar
• Fanne RA , Nassar T , Heyman SN , et al . Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate. Am J Physiol Regul Integr Comp Physiol. 2011;301:R668–R673.10.1152/ajpregu.00058.2011
   PubMed Web of Science ®Google Scholar
• Louraki M , Katsalouli M , Kanaka-Gantenbein C , et al . The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2). Diabetes Res Clin Pract. 2016;117:82–90.10.1016/j.diabres.2016.04.044
   PubMed Web of Science ®Google Scholar
• Wang XL , Zhang HM , Chen SR , et al . Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy. J Physiol. 2007;579:849–861.10.1113/jphysiol.2006.126102
   PubMed Web of Science ®Google Scholar
• Miller KE , Hoffman EM , Sutharshan M , et al . Glutamate pharmacology and metabolism in peripheral primary afferents: Physiological and pathophysiological mechanisms. Pharmacol Ther. 2011;130:283–309.10.1016/j.pharmthera.2011.01.005
   PubMed Web of Science ®Google Scholar
• Zhuo M . Ionotropic glutamate receptors contribute to pain transmission and chronic pain. Neuropharmacology. 2017;112:228–234.10.1016/j.neuropharm.2016.08.014
   PubMed Web of Science ®Google Scholar
• Chiechio S . Modulation of chronic pain by metabotropic glutamate receptors. Adv Pharmacol. 2016;75:63–89.10.1016/bs.apha.2015.11.001
   PubMedGoogle Scholar
• Daulhac L , Mallet C , Courteix C , et al . Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms. Mol Pharmacol. 2006;70:1246–1254.10.1124/mol.106.025478
   PubMed Web of Science ®Google Scholar
• Mert T , Oksuz H , Tugtag B , et al . Modulating actions of NMDA receptors on pronociceptive effects of locally injected remifentanil in diabetic rats. Pharmacol Rep. 2014;66:1065–1072.10.1016/j.pharep.2014.07.004
   PubMed Web of Science ®Google Scholar
• Petrenko AB , Yamakura T , Baba H , et al . The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg. 2003;97:1108–1116.10.1213/01.ANE.0000081061.12235.55
   PubMed Web of Science ®Google Scholar
• Rondon LJ , Privat AM , Daulhac L , et al . Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain. J Physiol. 2010;588:4205–4215.10.1113/jphysiol.2010.197004
   PubMed Web of Science ®Google Scholar
• Kim JH , Roberts DS , Hu Y , et al . Brain-derived neurotrophic factor uses CREB and Egr3 to regulate NMDA receptor levels in cortical neurons. J Neurochem. 2012;120:210–219.10.1111/j.1471-4159.2011.07555.x
   PubMed Web of Science ®Google Scholar
• Lau GC , Saha S , Faris R , et al . Up-regulation of NMDAR1 subunit gene expression in cortical neurons via a PKA-dependent pathway. J Neurochem. 2004;88:564–575.10.1046/j.1471-4159.2003.02156.x
   PubMed Web of Science ®Google Scholar
• Yao CY , Weng ZL , Zhang JC , et al . Interleukin-17A acts to maintain neuropathic pain through activation of CaMKII/CREB signaling in spinal neurons. Mol Neurobiol. 2016;53:3914–3926.10.1007/s12035-015-9322-z
   PubMed Web of Science ®Google Scholar
• Descalzi G , Fukushima H , Suzuki A , et al . Genetic enhancement of neuropathic and inflammatory pain by forebrain upregulation of CREB-mediated transcription. Mol Pain. 2012;8:90.
   PubMed Web of Science ®Google Scholar
• Nakanishi M , Hata K , Nagayama T , et al . Acid activation of Trpv1 leads to an up-regulation of calcitonin gene-related peptide expression in dorsal root ganglion neurons via the CaMK-CREB cascade: a potential mechanism of inflammatory pain. Mol Biol Cell. 2010;21:2568–2577.10.1091/mbc.E10-01-0049
   PubMed Web of Science ®Google Scholar
• Feng H , Lu G , Li Q , et al . Inhibition of adenylyl cyclase in the spinal cord alleviates painful diabetic neuropathy in Zucker diabetic fatty rats. Can J Diabetes. 2017;41:177–183.10.1016/j.jcjd.2016.09.006
   PubMed Web of Science ®Google Scholar
• Goyal SN , Reddy NM , Patil KR , et al . Challenges and issues with streptozotocin-induced diabetes – a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chemico-Biol Interact. 2016;244:49–63.10.1016/j.cbi.2015.11.032
   PubMed Web of Science ®Google Scholar
• Haidara MA , Mikhailidis DP , Rateb MA , et al . Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes. J Diabetes Complications. 2009;23:130–136.10.1016/j.jdiacomp.2008.02.011
   PubMed Web of Science ®Google Scholar
• Huang K , Liu W , Lan T , et al . Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models. PLoS ONE. 2012;7:e43874.10.1371/journal.pone.0043874
   PubMed Web of Science ®Google Scholar
• Li L , Luo R , Fan P , et al . Role of peripheral purinoceptors in the development of bee venom-induced nociception: a behavioural and electrophysiological study in rats. Clin Exp Pharmacol Physiol. 2014;41:902–910.10.1111/cep.2014.41.issue-11
   PubMed Web of Science ®Google Scholar
• Wu J , Yan LJ . Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic beta cell glucotoxicity. Diabetes Metab Syndr Obes. 2015;8:181–188.
   PubMed Web of Science ®Google Scholar
• Gunduz O , Oltulu C , Buldum D , et al . Anti-allodynic and anti-hyperalgesic effects of ceftriaxone in streptozocin-induced diabetic rats. Neurosci Lett. 2011;491:23–25.10.1016/j.neulet.2010.12.063
   PubMed Web of Science ®Google Scholar
• Suzuki Y , Sato J , Kawanishi M , et al . Lowered response threshold and increased responsiveness to mechanical stimulation of cutaneous nociceptive fibers in streptozotocin-diabetic rat skin in vitro–correlates of mechanical allodynia and hyperalgesia observed in the early stage of diabetes. Neurosci Res. 2002;43:171–178.10.1016/S0168-0102(02)00033-0
   PubMed Web of Science ®Google Scholar
• Deli G , Bosnyak E , Pusch G , et al . Diabetic neuropathies: diagnosis and management. Neuroendocrinology. 2013;98:267–280.10.1159/000358728
   PubMed Web of Science ®Google Scholar
• Figueroa-Romero C , Sadidi M , Feldman EL . Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9:301–314.10.1007/s11154-008-9104-2
   PubMed Web of Science ®Google Scholar
• Hosseini A , Abdollahi M . Diabetic neuropathy and oxidative stress: therapeutic perspectives. Oxid Med Cell Longevity. 2013;2013: 168039.
   PubMed Web of Science ®Google Scholar
• Kim JE , Kim AR , Chung HY , et al . In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa . Phytother Res. 2003;17:481–484.10.1002/(ISSN)1099-1573
   PubMed Web of Science ®Google Scholar
• Yowtak J , Lee KY , Kim HY , et al . Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain. 2011;152:844–852.10.1016/j.pain.2010.12.034
   PubMed Web of Science ®Google Scholar
• Babizhayev MA , Strokov IA , Nosikov VV , et al . The role of oxidative stress in diabetic neuropathy: generation of free radical species in the glycation reaction and gene polymorphisms encoding antioxidant enzymes to genetic susceptibility to diabetic neuropathy in population of Type I diabetic patients. Cell Biochem Biophys. 2015;71:1425–1443.10.1007/s12013-014-0365-y
   PubMed Web of Science ®Google Scholar
• Sanchez AP , Sharma K . Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med. 2009;11:F752.10.1017/S1462399409001057
   Web of Science ®Google Scholar
• Welters A , Lammert E , Mayatepek E , et al . Need for better diabetes treatment: the therapeutic potential of NMDA receptor antagonists. Klinische Padiatrie. 2017;229:14–20.
   PubMed Web of Science ®Google Scholar
• Marquard J , Otter S , Welters A , et al . Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment. Nat Med. 2015;21:363–372.10.1038/nm.3822
   PubMed Web of Science ®Google Scholar
• Niesters M , Dahan A . Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain. Expert Opin Drug Metab Toxicol. 2012;8:1409–1417.10.1517/17425255.2012.712686
   PubMed Web of Science ®Google Scholar
• Jorum E , Warncke T , Stubhaug A . Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-d-aspartate (NMDA) receptor antagonist ketamine – a double-blind, cross-over comparison with alfentanil and placebo. Pain. 2003;101:229–235.10.1016/S0304-3959(02)00122-7
   PubMed Web of Science ®Google Scholar
• Carlezon WA Jr , Duman RS , Nestler EJ . The many faces of CREB. Trends Neurosci. 2005;28:436–445.10.1016/j.tins.2005.06.005
   PubMed Web of Science ®Google Scholar
• Johannessen M , Delghandi MP , Moens U . What turns CREB on? Cell Signalling. 2004;16:1211–1227.10.1016/j.cellsig.2004.05.001
   PubMed Web of Science ®Google Scholar
• Ji RR , Rupp F . Phosphorylation of transcription factor CREB in rat spinal cord after formalin-induced hyperalgesia: relationship to c-fos induction. J Neurosci. 1997;17:1776–1785.
   PubMed Web of Science ®Google Scholar
• Hang LH , Yang JP , Shao DH , et al . Involvement of spinal PKA/CREB signaling pathway in the development of bone cancer pain. Pharmacol Rep. 2013;65:710–716.10.1016/S1734-1140(13)71049-1
   PubMed Web of Science ®Google Scholar
• Yao YX , Zhang YF , Yang Y , et al . Spinal synaptic scaffolding protein Homer 1b/c regulates CREB phosphorylation and c-fos activation induced by inflammatory pain in rats. Neurosci Lett. 2014;559:88–93.10.1016/j.neulet.2013.11.049
   PubMed Web of Science ®Google Scholar
• Khan S , Shehzad O , Chun J , et al . Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-kappaB, MAPKs and CREB signaling cascades. Eur J Pharmacol. 2013;718:448–458.10.1016/j.ejphar.2013.07.039
   PubMed Web of Science ®Google Scholar
• Cui Y , Xu J , Dai R , et al . Change of p-CREB after surgical incisional pain in rat spinal cord. Zhong nan da xue xue bao Yi xue ban. J Cent S Univ Med Sci. 2010;35:833–839.
   Google Scholar
• Wang H , Li Y , Dun L , et al . Antinociceptive effects of oxymatrine from Sophora flavescens, through regulation of NR2B-containing NMDA receptor-ERK/CREB signaling in a mice model of neuropathic pain. Phytomedicine. 2013;20:1039–1045.10.1016/j.phymed.2013.04.012
   PubMed Web of Science ®Google Scholar
• Liu P , Guo WY , Zhao XN , et al . Intrathecal baclofen, a GABAB receptor agonist, inhibits the expression of p-CREB and NR2B in the spinal dorsal horn in rats with diabetic neuropathic pain. Can J Physiol Pharm. 2014;92:655–660.10.1139/cjpp-2013-0463
   PubMed Web of Science ®Google Scholar
• Song XS , Cao JL , Xu YB , et al . Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats. Acta Pharmacologica Sinica. 2005;26:789–798.10.1111/aphs.2005.26.issue-7
   PubMed Web of Science ®Google Scholar